TaqPath COVID-19 Multiplex Diagnostic Solution by Thermo Fisher Scientific

4.0
/
5.0
  |  1 reviews
In response to the novel coronavirus (SARS-CoV-2) outbreak, Thermo Fisher Scientific has worked rapidly to develop a new multiplex real-time RT-PCR diagnostic kit to enable clinical and public health laboratories to quickly diagnose COVID-19 caused by SARS-CoV-2 infection. 


TaqPath COVID-19 Multiplex Diagnostic Solution by Thermo Fisher Scientific product image
TaqPath COVID-19 Multiplex Diagnostic Solution
Request Pricing

Receive your quote directly from the manufacturer.




Average Rating: 4.0
1 Scientist has reviewed this product

4 out of 5
Ease of use
4 out of 5
After sales service
4 out of 5
Value for money


  • Status:

    Reviewer
  • Member since: 2020

  • Organization: CCPM Biobank



  • Ease of use
    4 out of 5
    After sales service
    4 out of 5
    Value for money
    4 out of 5
Share this Review on LinkedinShare this Review on TwitterShare this Review on Facebook
Great.
Rating: 4.0

  • Application Area: PCR of COVID

"We are able to complete testing in a very short time."

Review date: 20 Nov 2020 | TaqPath COVID-19 Multiplex Diagnostic Solution

In response to the novel coronavirus (SARS-CoV-2) outbreak, Thermo Fisher Scientific has worked rapidly to develop a new multiplex real-time RT-PCR diagnostic kit to enable clinical and public health laboratories to quickly diagnose COVID-19 caused by SARS-CoV-2 infection. The Applied Biosystems TaqPath COVID-19 kit is a fast, highly sensitive multiplex diagnostic solution that contains both the assays and controls needed for the real-time PCR detection of RNA from the SARS-CoV-2 virus.

Product Overview

TaqPath COVID-19 Multiplex Diagnostic Solution by Thermo Fisher Scientific product image

TaqPath COVID-19 Multiplex Diagnostic Solution

Manufacturer Thermo Fisher Scientific

4.0 / 5.0 | 1 reviews